Name: ICUI Income Statement - Icu Medical Inc/de Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ICUI - Icu Medical Inc/de

USD | NASDAQ | Healthcare

ICUI Income Statement - Icu Medical Inc/de Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	530.2	540.7	537.0	548.9	604.7	629.8	589.1	596.5	566.7	587.9	553.3	549.3	568.6	578.0	597.9	561.0

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	2,156.8	2,231.3	2,382.0	2,259.1	2,280.0	1,316.3	1,271.0	1,266.2	1,400.0	1,292.6	379.4	341.7	309.3	313.7	316.9	302.2	283.0	229.0
Cost of Revenue	1,338.6	1,409.2	1,557.3	1,519.3	1,582.2	824.8	809.5	794.3	830.0	866.5	178.0	160.9	157.9	159.0	160.4	159.8	154.0	122.7
Gross Profit	818.2	822.0	824.8	739.9	697.8	491.5	461.5	471.9	570.0	426.1	201.4	180.8	151.4	154.7	156.5	142.4	129.0
Operating Expenses
Research & Development	85.5	87.5	88.6	85.3	93.0	47.5	42.9	48.6	52.9	51.3	13.0	15.7	18.3	12.4	10.6
Operating Income
Operating Income	43.5	42.8	43.0	22.8	(42.9)	123.2	98.2	107.4	29.8	(13.3)	82.9	68.6	39.0	51.9
Non-Operating
Interest Income	-	10.3	10.8	7.5	4.4	2.8	3.7	-	-	-	0.9	0.5	0.4	0.4	0.3	-
Tax & Net
Income Tax Expense	(36.8)	2.4	51.7	(48.6)	(40.1)	20.1	10.6	13.7	(6.4)	(17.4)	22.1	24.7	13.5	12.3	20.6
Per Share
EPS Basic	1.87	0.03	(4.83)	(1.23)	(3.11)	4.86	4.16	4.90	1.41	3.50	3.90	2.84	1.72	2.75	2.90	3.23
Supplementary Data
EBITDA	244.8	243.6	262.5	251.6	192.3	212.9	183.8	184.3	104.5	53.3	102.0	86.6	58.5	71.5	80.3	83.5

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	21.3	21.1	21.3	21.9	23.3	22.4	21.0	23.4	21.8	22.4	20.9	22.3	19.8	23.4	23.1	22.6	23.9	13.2	12.2	11.4	10.7	11.8	10.1	10.3	10.7	12.6	12.0	11.2	12.8	13.5	13.2	13.6	12.6	13.9	12.8	13.0	11.6	2.7	3.7	3.3
Selling General & Administrative	154.6	155.8	152.8	159.4	157.2	158.8	162.7	159.5	157.7	154.6	148.6	150.9	152.6	142.9	153.5	158.7
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	50.0	116.7	17.7	16.9	49.4	120.3	21.4	22.3	55.5	123.6	25.0	24.4	55.7	134.1	23.0	24.9
Amortization of Intangibles	33.1	33.0	33.1	32.7	32.6	33.8	34.3	33.1	33.1	33.3	33.4	33.1	32.3	30.5	35.6	41.6
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	192.6	197.4	187.2	197.5	197.2	189.6	196.6	199.7	195.9	183.8	161.1	189.6	182.6	175.2	186.9	167.6

Operating Income
Operating Income	13.6	5.6	13.7	10.6	12.9	37.7	8.2	7.7	(10.7)	(12.2)	22.9	2.8	9.4	(0.2)	(0.5)	(0.0)	(42.2)	23.8	38.4	34.5	26.6	27.0	25.5	19.6	26.1	17.8	32.9	26.3	30.4	(9.1)	2.3	31.7	4.9	43.3	(3.7)	(35.9)	(17.0)	13.8	22.5	22.8

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	16.5	31.0	19.8	20.5	22.0	34.2	24.7	23.8	23.8	31.9	24.2	24.1	22.5	24.5	17.8	15.4	13.1	0.4
Income From Equity Investments	(0.6)	(2.5)	(1.5)	2.8	0.0	-	0.0	0.0	-	-	-	-	-	-	-	-
Other Non-Operating Income	(1.1)	(0.9)	0.6	1.8	(1.8)	(6.0)	(1.5)	(3.4)	(2.3)	(0.1)	(4.0)	(1.5)	(0.3)	(1.2)	(3.0)	(1.4)	0.4
Pre-Tax Income	(4.0)	(15.9)	(2.5)	33.7	(10.9)	8.2	(17.9)	(19.5)	(36.8)	(36.7)	(5.4)	(22.9)	(13.4)	-	(21.3)	(16.9)

Tax & Net
Income Tax Expense	(34.7)	(2.7)	(0.7)	1.2	4.6	32.0	15.1	1.9	2.7	(19.5)	(12.6)	(12.9)	(3.6)	(5.9)	(8.1)	(9.4)	(16.7)	3.4	6.8	6.4	3.4	4.0	1.2	1.9	3.5	0.3	6.2	4.8	2.4	(5.1)	1.2	(1.5)	(1.1)	(9.8)	4.6	(2.1)	(10.0)	4.6	4.2	7.4
Net Income From Continuing Ops	30.1	(15.7)	(3.4)	35.3	(15.5)	(23.8)	(33.0)	(21.4)	(39.5)	(17.1)	7.2	(9.9)	(9.8)	(15.5)	(13.2)	(7.5)	(38.1)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	30.1	(15.7)	(3.4)	35.3	(15.5)	(23.8)	(33.0)	(21.4)	(39.5)	(17.1)	7.2	(9.9)	(9.8)	(15.5)	(13.2)	(7.5)	(38.1)
Net Income Attributable To Parent	30.1	(15.7)	(3.4)	35.3	(15.5)	(23.8)	(33.0)	(21.4)	(39.5)	(17.1)	7.2	(9.9)	(9.8)	(18.9)	(9.8)	(7.5)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	30.1	(15.7)	(3.4)	35.3	(15.5)	(23.8)	(33.0)	(21.4)	(39.5)	(17.1)	7.2	(9.9)	(9.8)	(18.9)	(9.8)

Per Share
EPS Basic	1.22	-	(0.14)	1.43	(0.63)	-	(1.35)	(0.88)	(1.63)	-	0.30	(0.41)	(0.41)	-	(0.55)	(0.31)	(1.61)	-	1.47	1.34	1.12	-	1.19	0.91	0.81	-	1.29	1.11	1.51	-	0.01	1.53	0.24	-	0.01	(1.87)	3.03	-	1.16	1.03
EPS Diluted	1.20	-	(0.14)	1.43	(0.63)	-	(1.35)	(0.88)	(1.63)	-	0.30	(0.41)	(0.41)	-	(0.55)	(0.31)	(1.61)	-
Shares Basic	24.8	-	24.7	24.6	24.5	-	24.4	24.4	24.2	-	24.1	24.1	24.0	-	23.9	23.9	23.6	-
Shares Diluted	25.2	-	24.7	24.7	24.5	-	24.4	24.4	24.2	-	24.4	24.1	24.0	-	23.9	23.9	23.6	-

Supplementary Data
EBITDA	63.6	122.3	31.4	27.5	62.3	158.0	29.6	30.0	44.9	111.4	47.9	27.2	65.1	133.9	22.5	24.9	11.0	58.7	54.8	50.8	48.7	60.3	41.1	35.4	47.0	46.2	47.7	41.0	49.4	18.6	17.4	45.3	23.2	69.9	10.3	(21.5)	(5.4)	-	26.5	-
EBIT	13.6	5.6	13.7	10.6	12.9	37.7	8.2	7.7	(10.7)	(12.2)	22.9	2.8	9.4	(0.2)	(0.5)	(0.0)	(42.2)	23.8	38.4